The de-marketing of smokeless tobacco for harm reduction

Journal of Consumer Marketing

Volumn 24, Issue 2, 2007, Pages 68-70

  Capella, Michael L ^a  

^a VILLANOVA UNIVERSITY   (United States)

Author keywords

Cigarettes; Risk management; Tobacco

Indexed keywords

EID: 33947249402     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760710737067     Document Type: Article

References (16)

1. Benowitz, N.L. (1988), “Pharmacologic aspects of cigarette smoking and nicotine addiction”, New England Journal of Medicine, Vol. 319 No. 20, pp. 318-30.
2. Center for Disease Control (2005), “Cigarette smoking among adults – United States, 2004”, Morbidity and Mortality Weekly Report, Vol. 54, pp. 1121-4.
3. Cummings, K.M. (2001), “Informing consumers about the relative health risks of different nicotine delivery products”, paper presented at the National Conference on Tobacco and Health, New Orleans, LA, November.
4. Cummings, K.M. (2002), “Can capitalism advance the goals of tobacco control?”, Addiction, Vol. 97, pp. 957-8.
5. Furberg, H., Bulik, C.M., Lerman, C., Lichtenstein, P., Pedersen, N.L. and Sullivan, P.F. (2005), “Swedish snus associated with smoking initiation or smoking cessation?”, Tobacco Control, Vol. 14, pp. 422-4.
6. Haddock, C.K., Lando, H., Klesges, R.C., Peterson, A.L. and Scarinci, I.C. (2004), “Modified tobacco use and lifestyle change in risk-reducing beliefs about smoking”, American Journal of Preventive Medicine, Vol. 27 No. 1, pp. 35-41.
7. Halpin, D. (2005), “Perceived safety of nicotine replacement products among general practitioners in the UK: impact of utilisation”, paper presented at the British Thoracic Society Winter Meeting, London, December 7-9.
8. Levy, D.T., Mumford, E.A., Cummings, K.M., Gilpin, E.A., Giovino, G., Hyland, A., Sweanor, D. and Warner, K.E. (2004), “The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts”, Cancer Epidemiology Biomarkers Prevention, Vol. 13 No. 12, pp. 2035-42.
9. Kozlowski, L.T. (2002), “Harm reduction, public health, and human rights: smokers have a right to be informed of significant reduction options”, Nicotine and Tobacco Research, Vol. 4, pp. 55-60.
10. Kozlowski, L.T. and Edwards, B.Q. (2005), “Not safe is not enough: smokers have a right to know more than there is no safe tobacco product”, Tobacco Control, Vol. 14, Supplement II, pp. ii3-ii7.
11. Kozlowski, L.T., Strasser, A.A., Giovino, G.A., Erickson, J.A. and Terza, J.V. (2001), “Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction”, Tobacco Control, Vol. 10, pp. 201-3.
12. Meister, K. (2006), Helping Smokers Quit: A Role for Smokeless Tobacco, American Council on Science and Health, New York, NY, October.
13. O'Connor, R.J., Hyland, A., Giovino, G., Fong, G.T. and Cummings, K.M. (2005), “Smoker awareness of and beliefs about supposedly less-harmful tobacco products”, American Journal of Preventive Medicine, Vol. 29 No. 2, pp. 85-90.
14. Phillips, C.V., Guenzel, B. and Bergen, P. (2006), “Deconstructing anti-harm-reduction metaphors: mortality risk from falls and other traumatic injuries compared to smokeless tobacco use”, Harm Reduction Journal, Vol. 3 No. 15, pp. 1-5.
15. Rodu, B. and Cole, P. (2004), “The burden of mortality from smoking: comparing Sweden with other countries in the European Union”, European Journal of Epidemiology, Vol. 19 No. 2, pp. 129-31.
16. Rodu, B. and Jansson, C. (2004), “Smokeless tobacco and oral cancer: a review of the risks and determinants”, Critical Review of Oral Biological Medicine, Vol. 15 No. 5, pp. 252-63.